MannKind Corporation (MNKD) Given Consensus Recommendation of "Hold" by Brokerages

Angelo Anderson
November 14, 2017

The stock of MannKind Corporation (NASDAQ:MNKD) has "Strong-Buy" rating given on Friday, August 28 by Vetr. With short interest at 26,337,802 and short average daily volume at 27,541,901, days to cover is 1.0 and the short interest percentage is 0.23% as of October 13. Currently, 41.1% of the shares of the company are short sold. The NYSE-listed company saw a recent bid of $7.47 on volume of 2.55 million shares.

Additionally on 10/10/17 H.C. Wainwright "Initiates Coverage On" Mannkind Corporation (NASDAQ:MNKD) to Buy setting price target at $7 and on 8/11/17 Maxim Group "Initiates Coverage On" the stock to Buy at $4. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. The consensus recommendation for stock is 2.00. Finally, HC Wainwright assumed coverage on MannKind Corporation in a report on Tuesday, October 10th. The MannKind Corporation has Relative Strength Index (RSI 14) of 45.42 along with Average True Range (ATR 14) of 0.56.

MannKind Corp. (MNKD) has the market capitalization of $371.04 Million. The company had a trading volume of 6,259,500 shares, compared to its average volume of 4,129,792. (NYSE:CHS) by 0.75% during the June 2017 quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. Macquarie Group Ltd. bought a new position in shares of MannKind Corporation in the 3rd quarter worth about $156,000. Finally, Harel Insurance Investments & Financial Services Ltd. increased its stake in MannKind Corporation by 20.1% during the 2nd quarter. The firm owned 2,702,403 shares of the company's stock after buying an additional 2,702,403 shares during the period. Hanson Mcclain, Inc. reduced its holdings by shedding 3,000 shares a decrease of 85.7% in the quarter. KCG Holdings Inc. now owns 147,952 shares of the biopharmaceutical company's stock valued at $219,000 after purchasing an additional 107,752 shares in the last quarter.

For the Current Quarter, the growth estimate for MannKind -137.5%, while for the Next Quarter the stock growth estimate is -52.9%.

In other news, Director Kent Kresa acquired 166,600 shares of the business's stock in a transaction on Friday, October 13th. Company insiders own 1.60% of the company's stock.

Shares of MannKind Corporation (NASDAQ:MNKD) traded down $0.02 on Monday, reaching $3.24. A frequently used tool among technical stock analysts is the moving average.

Voya Financial, Inc. (NYSE:VOYA) now has a PEG ratio of - where as its P/E ratio is 0.00. As MannKind Corporation has a P/S, P/E and P/B values of 18.93, 0 and 0 respectively.

Currently Mannkind Corporation (NASDAQ:MNKD)'s shares owned by insiders are 0.2%, whereas shares owned by institutional owners are 14.6%.

Previously Mannkind Corporation (NASDAQ:MNKD) reported $-0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $-0.2 by $-0.11. MannKind Corporation had a negative return on equity of 24.93% and a net margin of 71.60%. The business had revenue of $2.16 million during the quarter, compared to analyst estimates of $2.75 million.

EPS is the portion of a company's profit allocated to each exceptional share of common stock. The company's quarterly revenue was down 98.7% compared to the same quarter last year. equities analysts anticipate that MannKind Corporation will post -1.13 EPS for the current year.

WARNING: This article was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another publication, it was illegally stolen and republished in violation of USA & global copyright legislation.

The Shareholder Yield (Mebane Faber) of MannKind Corporation NasdaqGM:MNKD is 0.05241. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes.

Other reports by Iphone Fresh

Discuss This Article